Merit Medical Systems | MMSI - Gewinn Vor Steuern

Aktienkurs
66.69
Täglich Wechseln
-1.64 -2.40%
Monatlich
-18.28%
Jährlich
-34.41%
Q1 Prognose
67.84




Gewinn Vor Steuern Veränderung Datum
3M USD 759M 390M 2025-12
Abbott USD 2.36B 178M 2025-12
AngioDynamics USD -6.4M 5.03M 2025-09
Anika Therapeutics USD 764K 3M 2025-12
AtriCure USD 2.36M 2.45M 2025-12
Baxter International USD 121M 12M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 938M 3M 2025-09
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 300M 58.9M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Haemonetics USD 59.97M 8.69M 2025-12
Hologic USD 229.7M 2.3M 2025-12
ICU Medical USD 70.3M 36.62M 2025-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
J&J USD 4.97B 2.53B 2025-12
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 73.18M 29.8M 2025-09
Olympus JPY 22.13B 5.77B 2025-12
Pfizer USD 3.33B 290M 2025-09
STAAR Surgical USD 18.79M 44.7M 2025-09
Stryker USD 1.03B 13M 2025-09
Surmodics USD -7.51M 1.69M 2024-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Terumo JPY 45.38B 578M 2025-12
Zimmer Biomet Holdings USD 418.7M 194.1M 2025-09